Zymeworks Inc. Common Shares (ZYME): Price and Financial Metrics
ZYME Price/Volume Stats
| Current price | $12.73 | 52-week high | $17.70 |
| Prev. close | $13.05 | 52-week low | $7.97 |
| Day low | $12.67 | Volume | 280,543 |
| Day high | $13.28 | Avg. volume | 526,760 |
| 50-day MA | $13.66 | Dividend yield | N/A |
| 200-day MA | $12.51 | Market Cap | 885.72M |
ZYME Stock Price Chart Interactive Chart >
Zymeworks Inc. Common Shares (ZYME) Company Bio
Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The company was founded in 2003 and is based in Vancouver, BC.
ZYME Price Returns
| 1-mo | -11.54% |
| 3-mo | N/A |
| 6-mo | 2.09% |
| 1-year | 22.40% |
| 3-year | 81.86% |
| 5-year | -61.14% |
| YTD | -13.05% |
| 2024 | 40.90% |
| 2023 | 32.19% |
| 2022 | -52.04% |
| 2021 | -65.32% |
| 2020 | 3.96% |
Continue Researching ZYME
Here are a few links from around the web to help you further your research on Zymeworks Inc's stock as an investment opportunity:Zymeworks Inc (ZYME) Stock Price | Nasdaq
Zymeworks Inc (ZYME) Stock Quote, History and News - Yahoo Finance
Zymeworks Inc (ZYME) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...